-
-
The management of advanced, hormone-resistant prostate cancer remains challenging.
-
Controversy exists regarding the best approach to early epidermoid cancers of the lip. Various approaches have been advocated, including surgery with or without postoperative radiotherapy, and low- dose rate (LDR) brachytherapy.
-
The arimidex, tamoxifen alone or in combination (ATAC) trial is a large-scale, international, industry-sponsored interventional, randomized study involving almost 10,000 early-stage postmenopausal breast cancer patients who were randomized to receive either anastrozole alone or in combination with tamoxifen, or tamoxifen alone.
-
-
A substantial difference in clinical quality was found between the winners of the Health Grades Inc./J.D. Power & Associates Distinguished Hospital Award for Clinical Excellence winners and all other hospitals, Health Grades Inc. reports.
-
Connecting for Health, a collaborative of public and private stakeholders, will be launching a new phase of its effort to promote electronic connectivity in health care. The projects steering group, comprising more than 50 leaders and decision makers in the health care industry is committed to creating an incremental road map to achieving electronic connectivity.
-
The Breakthrough Series Collaborative model effectively employed by the Institute for Healthcare Improvement (IHI) on a national level has been translated successfully to the regional level in the state of Washington, achieving significant improvement in the self-care efforts of diabetes patients and clinical improvements in areas such as blood sugar and cholesterol.
-
Breaking with tradition is never easy, especially when it comes to such sensitive areas as the intensive care unit (ICU). But at Geisinger Medical Center in Danville, PA, a second attempt at instituting open visiting in the adult ICU is working so well that is has become official policy.
-
Traditionally, medical error disclosures have not occurred due to fears of liability, as well as credentialing, sanctioning, and licensing concerns. However, new research suggests that not disclosing a medical error actually can leave a health care provider in a worse position than if the provider had disclosed the medical error.
